Literature DB >> 33099451

Screening for Cervical Cancer.

Terresa J Eun1, Rebecca B Perkins2.   

Abstract

The most effective strategy for cervical cancer prevention involves vaccination to prevent human papillomavirus (HPV) infections during adolescence followed by screening to detect HPV infections during adulthood. HPV vaccination before sexual debut can prevent HPV infections, precancers, and cancers. HPV vaccination of sexually active populations does not prevent cancer. Screening with HPV testing is the most effective method of detecting precancers and cancers between ages 25 and 65. Ensuring adequate screening around the age of menopause may be the key to preventing cervical cancer among elderly women. Most cervical cancers at all ages occur among unscreened or underscreened women.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer screening; Cervical cytology; HPV test; PAP test

Mesh:

Year:  2020        PMID: 33099451      PMCID: PMC8881993          DOI: 10.1016/j.mcna.2020.08.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  81 in total

Review 1.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

Review 2.  Process of care failures in invasive cervical cancer: systematic review and meta-analysis.

Authors:  Andrea R Spence; Patricia Goggin; Eduardo L Franco
Journal:  Prev Med       Date:  2007-06-22       Impact factor: 4.018

Review 3.  Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.

Authors:  Gary Clifford; Silvia Franceschi; Mireia Diaz; Nubia Muñoz; Luisa Lina Villa
Journal:  Vaccine       Date:  2006-06-02       Impact factor: 3.641

4.  The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.

Authors:  H O Smith; M F Tiffany; C R Qualls; C R Key
Journal:  Gynecol Oncol       Date:  2000-08       Impact factor: 5.482

5.  Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Philip E Castle; Diane Solomon; Robert Burk
Journal:  J Natl Cancer Inst       Date:  2008-03-25       Impact factor: 13.506

6.  Human papillomavirus vaccination and cervical cytology in young minority women.

Authors:  Susan B Brogly; Rebecca B Perkins; Dimity Zepf; Janina Longtine; Shi Yang
Journal:  Sex Transm Dis       Date:  2014-08       Impact factor: 2.830

Review 7.  Global Cancer Incidence and Mortality Rates and Trends--An Update.

Authors:  Lindsey A Torre; Rebecca L Siegel; Elizabeth M Ward; Ahmedin Jemal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-14       Impact factor: 4.254

8.  Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.

Authors:  Marc Arbyn; Sara B Smith; Sarah Temin; Farhana Sultana; Philip Castle
Journal:  BMJ       Date:  2018-12-05

9.  Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program.

Authors:  Jiangrong Wang; K Miriam Elfström; Bengt Andrae; Sara Nordqvist Kleppe; Alexander Ploner; Jiayao Lei; Joakim Dillner; Karin Sundström; Pär Sparén
Journal:  Int J Cancer       Date:  2019-06-03       Impact factor: 7.396

10.  Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.

Authors:  Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Mario Alfaro; Jorge Morales; Diego Guillen; Mark E Sherman; Diane Solomon; Mark Schiffman
Journal:  BMJ       Date:  2009-07-28
View more
  5 in total

1.  Influence of ovarian-sparing surgery and ovariectomy on prognosis in early cervical adenocarcinoma: a systematic review and meta-analysis.

Authors:  Jiangxin Sheng; Yunhua Yi; Jichan Nie
Journal:  Gland Surg       Date:  2022-06

Review 2.  Prevalence of pelvic floor dysfunction and sexual dysfunction in cervical cancer survivors: a systematic review and meta-analysis.

Authors:  Xiao Shan; Maolin Qian; Lan Wang; Xiaoqin Liu
Journal:  Int Urogynecol J       Date:  2022-08-24       Impact factor: 1.932

3.  Relationship between positive margin and residual/recurrence after excision of cervical intraepithelial neoplasia: a systematic review and meta-analysis.

Authors:  Hailing Feng; Hai Chen; Dan Huang; Shengke He; Zhiqian Xue; Zhongjun Pan; Huajun Yu; Yongqun Huang
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

4.  Clinical Utility of Red Blood Cell Distribution Width for the Diagnosis and Prognosis of Cervical Cancer.

Authors:  Yanyan Li; Zhanzhan Li; Guangying Zhang
Journal:  Int J Gen Med       Date:  2022-03-06

5.  Cervical Cancer Prevention in the Era of the COVID-19 Pandemic.

Authors:  Patryk Poniewierza; Grzegorz Panek
Journal:  Medicina (Kaunas)       Date:  2022-05-29       Impact factor: 2.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.